Cytarabine release from α,β-poly(N-hydroxyethyl)-dl-aspartamide matrices cross-linked through γ-radiation

This publication has 18 references indexed in Scilit:

• Passive immunotherapy of cancer: perspectives and problems
  Journal of Controlled Release, 1991
• Macromolecular prodrugs for use in targeted cancer chemotherapy: melphalan covalently coupled to N- (2-hydroxypropyl) methacrylamide copolymers
  Journal of Controlled Release, 1991
• Properties of a 9-(2-phosphonylmethoxyethyl)adenine (PMEA)-resistant herpes simplex virus type 1 virus mutant
  Antiviral Research, 1990
• Antiviral effect of antileukemic drugs N4-Behenoyl-1-β-D-Arabinofuranosylcytosine (BH-AC) and 2,2′-Anhydro-1-β-D-Arabinofuranosylcytosine (Cyclo-C) Against Human Cytomegalovirus
  Journal of Medical Virology, 1990
• Differential toxicity of cytosine arabinoside to cell kinetics in normal sheep sinus cells and sheep tumour cell line in vitro
  Toxicology in Vitro, 1990
• Effect of cytosine arabinoside on the human immunosystem: metabolism and cytotoxicity studied with mitogen-stimulated normal blood lymphocytes in vitro
  International Journal of Immunopharmacology, 1988
• The synthesis and characterization of polypeptide-adriamycin conjugates and its complexes with adriamycin. Part I
  Journal of Controlled Release, 1985
• Cytosine arabinoside: Molecular, pharmacokinetic and cytokinetic considerations
  Pharmacology & Therapeutics, 1984
• Preparation of liposome-encapsulated anti-tumor drugs; Relationship between lipophilicity of drugs and in vitro drug release.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
• Synthesis of .alpha.,.beta.-poly [(2-hydroxyethyl)-DL-aspartamide], a newplasma expander
  Journal of Medicinal Chemistry, 1973